Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1902 1
1904 2
1905 1
1907 1
1926 1
1931 1
1938 1
1945 1
1947 2
1948 2
1949 1
1950 1
1951 1
1952 1
1953 1
1954 1
1955 2
1956 1
1958 1
1964 1
1969 1
1971 1
1973 1
1976 1
1977 2
1978 2
1979 2
1980 1
1981 2
1982 1
1983 2
1984 4
1985 1
1986 1
1987 1
1988 4
1989 2
1990 1
1991 6
1992 2
1993 4
1994 4
1995 7
1996 8
1997 8
1998 7
1999 11
2000 7
2001 16
2002 8
2003 11
2004 16
2005 19
2006 16
2007 23
2008 19
2009 25
2010 31
2011 40
2012 49
2013 41
2014 40
2015 40
2016 51
2017 46
2018 46
2019 50
2020 38
2021 52
2022 44
2023 44
2024 41
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

806 results

Results by year

Filters applied: . Clear all
Page 1
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study.
Cutler C, Lee SJ, Arai S, Rotta M, Zoghi B, Lazaryan A, Ramakrishnan A, DeFilipp Z, Salhotra A, Chai-Ho W, Mehta R, Wang T, Arora M, Pusic I, Saad A, Shah NN, Abhyankar S, Bachier C, Galvin J, Im A, Langston A, Liesveld J, Juckett M, Logan A, Schachter L, Alavi A, Howard D, Waksal HW, Ryan J, Eiznhamer D, Aggarwal SK, Ieyoub J, Schueller O, Green L, Yang Z, Krenz H, Jagasia M, Blazar BR, Pavletic S. Cutler C, et al. Blood. 2021 Dec 2;138(22):2278-2289. doi: 10.1182/blood.2021012021. Blood. 2021. PMID: 34265047 Free PMC article. Clinical Trial.
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease.
Wolff D, Cutler C, Lee SJ, Pusic I, Bittencourt H, White J, Hamadani M, Arai S, Salhotra A, Perez-Simon JA, Alousi A, Choe H, Kwon M, Bermúdez A, Kim I, Socié G, Chhabra S, Radojcic V, O'Toole T, Tian C, Ordentlich P, DeFilipp Z, Kitko CL; AGAVE-201 Investigators. Wolff D, et al. Among authors: cutler c. N Engl J Med. 2024 Sep 19;391(11):1002-1014. doi: 10.1056/NEJMoa2401537. N Engl J Med. 2024. PMID: 39292927 Clinical Trial.
Effects of Chlorhexidine mouthwash on the oral microbiome.
Bescos R, Ashworth A, Cutler C, Brookes ZL, Belfield L, Rodiles A, Casas-Agustench P, Farnham G, Liddle L, Burleigh M, White D, Easton C, Hickson M. Bescos R, et al. Among authors: cutler c. Sci Rep. 2020 Mar 24;10(1):5254. doi: 10.1038/s41598-020-61912-4. Sci Rep. 2020. PMID: 32210245 Free PMC article.
Hematopoietic Cell Transplantation in the Management of Myelodysplastic Syndrome: An Evidence-Based Review from the American Society for Transplantation and Cellular Therapy Committee on Practice Guidelines.
DeFilipp Z, Ciurea SO, Cutler C, Robin M, Warlick ED, Nakamura R, Brunner AM, Dholaria B, Walker AR, Kröger N, Bejanyan N, Atallah E, Tamari R, Solh MM, Percival ME, de Lima M, Scott B, Oran B, Garcia-Manero G, Hamadani M, Carpenter P, DeZern AE. DeFilipp Z, et al. Among authors: cutler c. Transplant Cell Ther. 2023 Feb;29(2):71-81. doi: 10.1016/j.jtct.2022.11.014. Epub 2022 Nov 25. Transplant Cell Ther. 2023. PMID: 36436780 Free article. Review.
Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force.
Cuvelier GDE, Schoettler M, Buxbaum NP, Pinal-Fernandez I, Schmalzing M, Distler JHW, Penack O, Santomasso BD, Zeiser R, Angstwurm K, MacDonald KPA, Kimberly WT, Taylor N, Bilic E, Banas B, Buettner-Herold M, Sinha N, Greinix HT, Pidala J, Schultz KR, Williams KM, Inamoto Y, Cutler C, Griffith LM, Lee SJ, Sarantopoulos S, Pavletic SZ, Wolff D. Cuvelier GDE, et al. Among authors: cutler c. Transplant Cell Ther. 2022 Aug;28(8):426-445. doi: 10.1016/j.jtct.2022.05.038. Epub 2022 May 31. Transplant Cell Ther. 2022. PMID: 35662591 Free PMC article. Review.
Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML.
Garcia JS, Kim HT, Murdock HM, Ansuinelli M, Brock J, Cutler CS, Gooptu M, Ho VT, Koreth J, Nikiforow S, Romee R, Shapiro R, DeAngelo DJ, Stone RM, Bat-Erdene D, Ryan J, Contreras ME, Fell G, Letai A, Ritz J, Lindsley RC, Soiffer RJ, Antin JH. Garcia JS, et al. Among authors: cutler cs. Blood Adv. 2024 Feb 27;8(4):978-990. doi: 10.1182/bloodadvances.2023012120. Blood Adv. 2024. PMID: 38197938 Free PMC article.
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy.
Miklos D, Cutler CS, Arora M, Waller EK, Jagasia M, Pusic I, Flowers ME, Logan AC, Nakamura R, Blazar BR, Li Y, Chang S, Lal I, Dubovsky J, James DF, Styles L, Jaglowski S. Miklos D, et al. Among authors: cutler cs. Blood. 2017 Nov 23;130(21):2243-2250. doi: 10.1182/blood-2017-07-793786. Epub 2017 Sep 18. Blood. 2017. PMID: 28924018 Free PMC article. Clinical Trial.
Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study.
Horwitz ME, Stiff PJ, Cutler C, Brunstein C, Hanna R, Maziarz RT, Rezvani AR, Karris NA, McGuirk J, Valcarcel D, Schiller GJ, Lindemans CA, Hwang WYK, Koh LP, Keating A, Khaled Y, Hamerschlak N, Frankfurt O, Peled T, Segalovich I, Blackwell B, Wease S, Freedman LS, Galamidi-Cohen E, Sanz G. Horwitz ME, et al. Among authors: cutler c. Blood. 2021 Oct 21;138(16):1429-1440. doi: 10.1182/blood.2021011719. Blood. 2021. PMID: 34157093 Free PMC article. Clinical Trial.
806 results